pharmaceutical investing Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808
Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
